Natera Recognized on U.S. News & World Report’s 2024 Best Companies to Work for in Healthcare Ranking
19 Outubro 2023 - 10:00AM
Business Wire
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA
testing, today announced that it has been named by U.S. News &
World Report as one of the best companies to work for in
healthcare.
Natera was ranked among 349 companies across 20 fields of work
on factors contributing to job seekers’ decision-making when
choosing a workplace that best meets their needs in their
industries of interest. In healthcare specifically, Natera earned a
spot on the industry list alongside companies across different
elements of healthcare operations and services, including
biotechnology, life sciences, pharmaceuticals, and hospital
operations.
“At Natera, we are committed to fostering a positive workplace
environment where employees can learn from one another, further
develop in their careers, and continue to thrive – all while
contributing to our very important mission,” said Steve Chapman,
chief executive officer of Natera. “Natera is a great place to work
because of our extremely talented employees, and we are proud to
earn a spot on this list alongside so many esteemed companies
across different dimensions of healthcare.”
This new recognition by U.S. News expands on the general
2023-2024 U.S. News Best Companies to Work For list by looking at
how companies measure up to the expectations of their employees
within their respective industries. The rankings take into account
quality of pay, work-life balance, and opportunities for
professional development and advancement by industry.
To calculate the U.S. News Best Companies to Work For by
Industry lists, U.S. News only considered companies that were a
part of the Russell 3000 index as of June 2023 and scored in the
top 20% of their industry. Additionally, U.S. News required each
company to have a minimum of 75 Glassdoor reviews written between
2020-2022 and grouped companies according to the Industry
Classification Benchmark (ICB) used by the FTSE Russell.
To learn more about career opportunities at Natera and the core
values that define company culture, please visit:
www.natera.com/company/careers/.
About Natera
Natera™ is a global leader in cell-free DNA testing, dedicated
to oncology, women’s health, and organ health. We aim to make
personalized genetic testing and diagnostics part of the standard
of care to protect health, and inform earlier, more targeted
interventions that help lead to longer, healthier lives. Natera’s
tests are validated by more than 150 peer-reviewed publications
that demonstrate high accuracy. Natera operates ISO 13485-certified
and CAP-accredited laboratories certified under the Clinical
Laboratory Improvement Amendments (CLIA) in Austin, Texas and San
Carlos, California. For more information, visit www.natera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231019370305/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc.,
510-826-2350, investor@natera.com Media: Lesley Bogdanow, VP of
Corporate Communications, Natera, Inc., pr@natera.com
Natera (NASDAQ:NTRA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Natera (NASDAQ:NTRA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024